Funding Status: M&A
Headquarters: Ann Arbor, Michigan, United States
Founded Date: 2009
Last Funding Type: Venture - Series Unknown
Total Funding: $106M
Estimated Revenue: Less than $1M
Industry: Gene Therapy
Investors Number: 12
Technology: Neurological Disorders